Senate Bill 2246
116th Congress(2019-2020)
Allergy Testing Access Act of 2019
Introduced
Introduced
Introduced in Senate on Jul 24, 2019
Overview
Text
Introduced
Jul 24, 2019
Latest Action
Jul 24, 2019
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
2246
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Kansas
Connecticut
Michigan
South Carolina
No Senate votes have been held for this bill.
Summary

Allergy Testing Access Act of 2019

This bill requires equal coverage of two types of allergy tests under Medicaid and Medicare.

Specifically, in vitro specific IgE tests (blood tests) and percutaneous tests (skin tests) must be treated equally with respect to (1) medical necessity or other coverage requirements, (2) frequency limits, and (3) allergen unit limits.

Text (1)
Actions (2)
07/24/2019
Read twice and referred to the Committee on Finance.
07/24/2019
Introduced in Senate
Public Record
Created
Jul 25, 2019 4:42:14 AM
Updated
Feb 1, 2021 10:22:49 PM